HRTX logo
Heron Therapeutics, Inc.(HRTX)
Last print unknown agoAbout this dataData status
$0.36▼-0.00 (-0.03%)Stale · unknown oldEarnings · Nov 3

HRTX R&D Expenses

$12.30MTTM · USD

Period ending:

HRTX FY R&D ExpensesUSD
HRTX FY R&D Expenses1987-12-31: $0.001988-12-31: $0.001989-12-31: $0.001990-12-31: $0.001991-12-31: $0.001992-12-31: $0.001993-12-31: $0.001994-12-31: $6.30M1995-12-31: $4.10M1996-12-31: $3.50M1997-12-31: $3.70M1998-12-31: $4.40M1999-12-31: $4.30M2000-12-31: $3.71M2001-12-31: $7.35M2002-12-31: $6.70M2003-12-31: $8.66M2004-12-31: $11.50M2005-12-31: $10.30M2006-12-31: $15.24M2007-12-31: $19.36M2008-12-31: $19.51M2009-12-31: $7.80M2010-12-31: $7.26M2011-12-31: $8.21M2012-12-31: $15.05M2013-12-31: $32.78M2014-12-31: $54.83M2015-12-31: $61.18M2016-12-31: $103.13M2017-12-31: $138.58M2018-12-31: $140.03M2019-12-31: $167.38M2020-12-31: $174.53M2021-12-31: $130.82M2022-12-31: $82.70M2023-12-31: $39.13M2024-12-31: $16.68M2025-12-31: $12.43M$174.53M$0.00
1987-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

HRTX r&d expenses history

Research and development spending. The available annual fiscal periods series contains 39 observations from Dec 31, 1987 to Dec 31, 2025.

Heron Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
12,429,000
16,683,000
39,133,000
82,704,000
130,821,000
174,533,000
167,382,000
140,032,000
138,582,000
103,125,000
61,183,000
54,833,000
32,780,000
15,045,000
8,207,000
7,264,000
7,796,000
19,507,000
19,364,000
15,236,000
10,299,000
11,495,000
8,660,000
6,699,000
7,348,000
3,713,000
4,300,000
4,400,000
3,700,000
3,500,000
4,100,000
6,300,000
0
0
0
0
0
0
0

Compare r&d expenses

All HRTX financial metrics · HRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.